STOK STOKE THERAPEUTICS INC Management Changes 8-K Filing 2024 - Appointment of CFO and Resignation of CFO Stoke Therapeutics appointed Thomas Leggett as Chief Financial Officer, while Stephen J. Tulipano resigned from his position as CFO.Get access to all SEC 8-K filings of the STOKE THERAPEUTICS INC